William E Fantegrossi
Overview
Explore the profile of William E Fantegrossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali N, Kennon-McGill S, Parker L, James L, Fantegrossi W, McGill M
Toxicol Sci
. 2025 Mar;
PMID: 40065514
Acetaminophen (APAP) is the most-used over-the-counter analgesic among pregnant women. However, concerns have arisen over the safety of APAP exposure during gestation. In particular, it's been speculated that the hepatotoxic...
2.
Kaur H, Karabulut S, Gauld J, Fagot S, Holloway K, Shaw H, et al.
Psychedelic Med (New Rochelle)
. 2025 Mar;
1(3):166-185.
PMID: 40046567
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental syndromes diagnostically characterized by deficits in social communication and social interaction and repetitive, inflexible patterns of behaviors, interests, and thoughts. ASD...
3.
Fantegrossi W, Gannon B
J Pharmacol Exp Ther
. 2024 Sep;
391(1):18-21.
PMID: 39293859
No abstract available.
4.
Gannon B, Fitzgerald L, Godwin C, Hughes-Meredith H, Rice K, Fantegrossi W
Drug Alcohol Depend
. 2024 Feb;
256:111129.
PMID: 38395705
No abstract available.
5.
Shaw H, Patel D, Gannon B, Fitzgerald L, Carbonaro T, Johnson C, et al.
J Pharmacol Exp Ther
. 2024 Jan;
390(1):14-28.
PMID: 38272671
Abuse of novel arylcyclohexylamines (ACX) poses risks for toxicities, including adverse neurocognitive effects. In vivo effects of ring-substituted analogs of phencyclidine (PCP), eticyclidine (PCE), and ketamine are understudied. Adult male...
6.
Fitzgerald L, Gannon B, Walther D, Landavazo A, Hiranita T, Blough B, et al.
Neuropharmacology
. 2023 Dec;
245:109827.
PMID: 38154512
Substitutions to the phenethylamine structure give rise to numerous amphetamines and cathinones, contributing to an ever-growing number of abused novel psychoactive substances. Understanding how various substitutions affect the pharmacology of...
7.
Avram M, Bodinger C, Clark M, Stuckey D, Mathews S, Stogsdill S, et al.
Chem Res Toxicol
. 2023 Sep;
PMID: 37703190
Forensic laboratories need quick and simple technology to improve turnaround times, while delivering reliable results. The goal of this study is first to create a simplified workflow to meet new...
8.
Gannon B, Fitzgerald L, Godwin C, Hughes-Meredith H, Rice K, Fantegrossi W
Drug Alcohol Depend
. 2023 Aug;
250:110917.
PMID: 37579623
Background: Humans often administer psychostimulants in party or music festival settings characterized by warm ambient temperatures, which may impact drug effects; however, preclinical studies rarely investigate drug effects at multiple...
9.
Crosby S, Ahmed I, Osborn L, Wang Z, Schleiff M, Fantegrossi W, et al.
Metabolites
. 2022 Aug;
12(8).
PMID: 36005645
In 2019, synthetic cannabinoids accounted for more than one-third of new drugs of abuse worldwide; however, assessment of associated health risks is not ethical for controlled and often illegal substances,...
10.
Wilson C, Zheng F, Fantegrossi W
Psychopharmacology (Berl)
. 2022 Aug;
239(10):3237-3248.
PMID: 35933518
Rationale: Synthetic cannabinoid receptor agonists (SCRAs) are found in illicit smoking products, such as "K2" or "Spice." Convulsions are commonly reported adverse effects of SCRAs but are poorly understood. Objectives:...